Antisense strategies targeting protein kinase C: Preclinical and clinical development

被引:39
作者
Tortora, G
Ciardiello, F
机构
[1] Univ Naples Federico II, Cattedra Oncol Med, Dipart Endocrinol & Oncol Mol & Clin, I-80131 Naples, Italy
[2] Univ Naples 2, Dept Expt & Clin Med F Magrassi, Naples, Italy
关键词
D O I
10.1016/S0093-7754(03)00282-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:26 / 31
页数:6
相关论文
共 40 条
[1]  
AHMAD S, 1992, MOL PHARMACOL, V42, P1004
[2]  
ALAVI JB, 2000, P AN M AM SOC CLIN, V19, P167
[3]   Novel mechanisms for antisense-mediated regulation of gene expression [J].
Baker, BF ;
Monia, BP .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01) :3-18
[4]   THE POTENTIAL OF PROTEIN-KINASE-C AS A TARGET FOR ANTICANCER TREATMENT [J].
BASU, A .
PHARMACOLOGY & THERAPEUTICS, 1993, 59 (03) :257-280
[5]   Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-α (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides:: Relationship to the decreased viability of T24 bladder and PC3 prostate cancer cells [J].
Benimetskaya, L ;
Miller, P ;
Benimetsky, S ;
Maciaszek, A ;
Guga, P ;
Beaucage, SL ;
Wilk, A ;
Grajkowski, A ;
Halperin, AL ;
Stein, CA .
MOLECULAR PHARMACOLOGY, 2001, 60 (06) :1296-1307
[6]   Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer [J].
Cardenal, F ;
López-Cabrerizo, MP ;
Antón, A ;
Alberola, V ;
Massuti, B ;
Carrato, A ;
Barneto, I ;
Lomas, M ;
García, M ;
Lianes, P ;
Montalar, J ;
Vadell, C ;
González-Larriba, JL ;
Nguyen, B ;
Artal, A ;
Rosell, R .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :12-18
[7]  
Cartee L, 1998, ONCOL RES, V10, P371
[8]   Protein kinase c isoenzyme patterns characteristically modulated in early prostate cancer [J].
Cornford, P ;
Evans, J ;
Dodson, A ;
Parsons, K ;
Woolfenden, A ;
Neoptolemos, J ;
Foster, CS .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :137-144
[9]  
Crooke ST, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P1
[10]   INHIBITION OF PROTEIN-KINASE C-ALPHA EXPRESSION IN MICE AFTER SYSTEMIC ADMINISTRATION OF PHOSPHOROTHIOATE ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
DEAN, NM ;
MCKAY, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11762-11766